Oxonic acid potassium salt - CAS 2207-75-2
Catalog: |
BB017347 |
Product Name: |
Oxonic acid potassium salt |
CAS: |
2207-75-2 |
Synonyms: |
potassium;4,6-dioxo-1H-1,3,5-triazine-2-carboxylate |
IUPAC Name: | potassium;4,6-dioxo-1H-1,3,5-triazine-2-carboxylate |
Description: | Oxonic acid potassium salt is an inhibitor of uricase. It has been used for the inhibition of 5-fluorouracil-induced gastrointestinal toxicity without the loss of its antitumor activity in rats. It has also been used to induce hyperuricemia in rats; as it inhibits uric acid metabolism. |
Molecular Weight: | 195.17 |
Molecular Formula: | C4H2KN3O4 |
Canonical SMILES: | C1(=NC(=O)NC(=O)N1)C(=O)[O-].[K+] |
InChI: | InChI=1S/C4H3N3O4.K/c8-2(9)1-5-3(10)7-4(11)6-1;/h(H,8,9)(H2,5,6,7,10,11);/q;+1/p-1 |
InChI Key: | IAPCTXZQXAVYNG-UHFFFAOYSA-M |
Purity: | > 98 % |
MDL: | MFCD00010565 |
LogP: | -3.17830 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113491743-A | Pharmaceutical composition for preventing and treating avian gout diseases and preparation method and application thereof | 20210804 |
CN-113499357-A | Tea extract of sparrow mouth for treating hyperuricemia and related diseases, and preparation method, preparation and application thereof | 20210730 |
CN-113318201-A | Health food for reducing uric acid and preparation method thereof | 20210615 |
CN-113143972-A | Application of streptococcus thermophilus TIMR0705-6 in preparation of anti-hyperuricemia and anti-gout drugs | 20210519 |
CN-113321699-A | Preparation method and application of anserine cholate | 20210508 |
PMID | Publication Date | Title | Journal |
34044073 | 20210801 | Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy | Toxicology and applied pharmacology |
33749747 | 20210527 | Allopurinol Protects Against Cholestatic Liver Injury in Mice Not Through Depletion of Uric Acid | Toxicological sciences : an official journal of the Society of Toxicology |
24588444 | 20140319 | Identification of antihyperuricemic peptides in the proteolytic digest of shark cartilage water extract using in vivo activity-guided fractionation | Journal of agricultural and food chemistry |
22856880 | 20121101 | Hypouricemic effect of the methanol extract from Prunus mume fruit in mice | Pharmaceutical biology |
22967667 | 20121011 | Uricosuric and nephroprotective properties of Ramulus Mori ethanol extract in hyperuricemic mice | Journal of ethnopharmacology |
Complexity: | 274 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 194.96823704 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 194.96823704 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 111 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
-
Catalog: BB013066
1,3,5-Tribromo-1,3,5-triazinane-2,4,6-trione
Detail
-
Catalog: BB037932
2-(3-Bromophenyl)-4,6-diphenyl-1,3,5-triazine
Detail
-
Catalog: BB041720
1,2,4-triazine-3-carbaldehyde
Detail
-
Catalog: BB032605
1,2,4-triazine-3-carboxylic acid
Detail
-
Catalog: BB013318
1,3,5-Triazine-2,4,6-trithiol trisodium salt solution
Detail
-
Catalog: BB018923
1,3,5-Tribenzylhexahydro-1,3,5-triazine
Detail
-
Catalog: BB010176
2-(4-Biphenylyl)-4-chloro-6-phenyl-1,3,5-triazine
Detail
-
Catalog: BB037118
1,3,5-Tris(2-hydroxyethyl)isocyanurate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Triazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS